Introduction microRNAs (miRNAs) are a class of small, regulatory, noncoding RNAs. miRNA was discovered in C. elegans in 1993 by the Ambros and Ruvkun laboratories [1, 2]. The founding members of this class of RNAs include lin-4 and let-7. In 2001, interest in the field peaked when hundreds of miRNAs were discovered in Drosophila, C. elegans and mammals
. Over the past 7 years, numerous miRNAs have been discovered in many species including 678 in human, 472 in mouse and 154 in C. elegans [6] . miRNA represents a new class of gene regulation; it has been estimated that miRNA regulates up to one-third of human genes [7] . A number of excellent reviews on various aspects of miRNA have been published including overviews [8, 9] , miRNA processing [10] , post-transcriptional regulation of miRNA [11] and effect of RNA editing on miRNA [12] . This article reviews the literature on the regulation of miRNA processing that occurs within normal cells, during development or in diseases such as cancer. [17] . The complex contains a yardstick to measure the hairpin and to allow precise processing of the pri-miRNA [18] . Processing of the pri-miRNA appears to proceed prior to splicing [14] . The pre-miRNA contains the 2 nt 3' overhang that is characteristic of Dicer processing of siRNA. The pre-miRNA is transported to the cytoplasm by Exportin 5, a Ran-GTP-dependent mechanism [19] . Once [20] . Nucleotides 2 through 8 on the 5' end of the mature miRNA, the so-called 5' seed, interact with the reverse complement sequences on the mRNA. In situations of perfect complimentarity, the mRNA will be cleaved [21] . In animals, it is more likely that the miRNA will bind to the mRNA through imperfect complimentarity and produce translational repression. Translational repression proceeds without cleavage of the mRNA [22] . Translational repression is believed to occur by blocking translation, often by inhibiting translational initiation [23, 24] . miRNAs have been shown to be sequestered into processingbodies (P-bodies) [25] . The role of P-bodies in target repression and miRNA biogenesis remain unclear. Knockdown of Drosha and DGCR8 resulted in a loss of the P-bodies suggesting that they are a consequence, rather than the cause, of miRNA biogenesis [26] .
• Introduction

Regulation of microRNA processing during development, differentiation and normal cell function
Conceivably, production of the mature miRNA may be regulated at multiple steps in the biogenesis process (Fig. 1) [27] . The precursor to miR-38 was evident during all stages of development, however the mature miR-38 was present only in the embryonic stage [27] .
Various members of the let-7 family were regulated posttranscriptionally during neural differentiation of embryocarcinoma cells [28] . The levels of the precursor forms of the miRNAs were consistent during differentiation, whereas the mature form increased [28] . An increase in the let-7 precursor processing activity in vitro during neural differentiation of embryocarcinoma cells demonstrated that regulation occurred at the Dicer processing step [28] . Similar to [27] , Thomson et al. showed that the levels of mature let-7g (but not precursor) miRNAs increased during development of the mouse [29] [35] . Therefore, the presence of some unknown inhibitory factor appears to be preventing processing of pre-miR-138-2 in the cytoplasm of HeLa cells. These authors have developed a protocol to assist in the identification of cytoplasmic, inhibitory factors of miRNA processing [36] .
The miR-17-92 polycistron is composed of six miRNA precursors (i.e. miR -17, -18a, -19a, -19b-1, -20a and -92-1) . Forced expression of the polycistron along with c-myc was tumourigenic, suggesting that this group of miRNAs may function as oncogenes [37] . The splicing regulatory factor heterogeneous nuclear ribonucleoprotein (hnRNP) A1 is required for Drosha processing of miR-18a from the primary precursor [38] . hnRNP A1 was shown to interact specifically with the miR-18a hairpin and this interaction occurred prior to the processing by Drosha [7] . Using RNA interference knockdown of hnRNP A1, it was shown that miR-18a and not the other five miRNAs on the pri-miRNA required hnRNP A1 for processing. This is the first example of an hnRNP regulating the processing of miRNA. There are at least 28 known human hnRNPs and mRNA-protein complex proteins (mRNPs) [39] . Conceivably, some of these hnRNPs or mRNPs may be involved in regulating the processing of other miRNAs.
Effects of RNA editing on miRNA processing
RNA editing is a process in which adenosine deaminases (ADARs) convert adenosine to inosine on double-stranded RNA (reviewed in [40] [45] . Northern blotting and miRNA microchip analysis showed a reduction in the mature miR-16 and -15a in patients harbouring these mutations.
Ten SNPs were identified among 173 human pre-miRNA genes from 96 subjects [46] . Each of these SNPs was located in the stem or loop region of the pre-miRNA. With the exception of miR-30c (C-A polymorphism), the effects of these SNPS on miRNA processing were not evaluated. Pre-miRNA expression vectors harbouring either the wild-type or A SNP were processed to the mature form in CHO or HEK293T cells, demonstrating that this particular SNP had no effect on miRNA processing [46] . A total of 323 SNPs were identified among 227 human miRNA genes; 12 were located within miRNA precursors [47] . A G-U polymorphism was located at the ϩ8 position of the mature form of miR-125a. Transfection of HEK393T cells with a vector expressing the G or U forms of the miR-125a precursor demonstrated that only the G form was processed into mature miR-125a [47] . Using quantitative RT-PCR and primers specific to the pri-and pri-/pre-forms, it was shown that miRNA biogenesis was blocked at the level of prito pre-miR-125a processing [47] . This G-U SNP introduced basepairing mismatches, altered free energy values and created an enlarged RNA bulge in the predicted secondary structure of the miRNA precursor.
Examples of altered miRNA processing in cancer
Numerous studies have identified widespread alterations in the expression of miRNAs in human cancer (reviewed in [48, 49] [51] [52] [53] , let-7 [54] , miR-199a, -199a* [55] [56] [57] and 122a [56, 58] [67, 68] , (ii) epigenetic regulation of miRNA expression [69, 70] and (iii) abnormalities in miRNA processing. This review will discuss only the later mechanism. [52] . Furthermore, the genomic loci of the majority of the cancer cell lines were unchanged and alterations in DNA methylation among the cell lines did not occur [52] . [72] . Mature miR-7 was predominately reduced in glioblastoma tumours and in the glioblastoma cell line U87MG [72] . The mature miR-7 is processed from three different primary precursors, miR-7-1, miR-7-2 and miR-7-3. Using a quantitative PCR approach, levels of all three pri-miR-7 isoforms were similar between the glioblastomas and the normal tissues, however the levels of the pre-miR-7 isoforms were reduced in the glioblastomas [72] . The reduction in the miR-7 processing was shown to occur at the pri-to pre-miRNA level and not at the pre-miRNA to mature level and was specific to the U87MG cell line and not to HeLa cells [72] . [73] . [74] . The expression of Drosha as well as other genes on chromosome 5p was increased in cervical cancer [75] . In a tissue micro-array consisting of 232 prostate specimens, Dicer protein was found to be up-regulated in prostatic intraepithelial neoplasia and in 81% of the prostate adenocarcinomas [76] . It was proposed that increased Dicer expression in prostate carcinoma was partially responsible to explain the global increased miRNA expression in prostate cancer that was identified by this group [76] . However, others have concluded that there is a predominate reduced expression of miRNAs in prostate cancer [73, 77, 78] , so a conclusion on the contribution of Dicer expression in prostate cancer awaits further study.
The initial study demonstrating the relationship between alterations in miRNA processing in cancer was that of Michael et al. [51]. Two miRNAs, miR-143 and miR-145, had reduced expression of the mature form in colorectal adenocarcinoma compared to the matched normal mucosa. Interestingly, the Northern blots showed that the levels of pre-miR-143 and -145 were identical between the tumour and normal tissues. These authors went on to examine the miR-143 and -145 expression in several cancer cell lines and showed that like the tumours, the cell lines had reduced levels of mature miRNA, whereas equivalent levels of the precursors were detectable. Thus, the reduction in mature miR-143 and -145 in colorectal cancer cell lines and tissues is a result of reduced processing of the miRNA precursors. miR-143 was subsequently shown to target ERK5 [71]. ERK5 is a growth-related mitogen-activated protein kinase. Transfection of a miR-143 and miR-145 precursor oligonucleotides into colorectal carcinoma cell lines reduced cell viability and reduced the levels of ERK5 protein
miR-143 and -145 was found to be reduced in most of the B-cell malignancies examined, including chronic lymphocytic leukaemias, B-cell lymphomas, Epstein-Barr virus-transformed B-cell lines and Burkitt lymphoma cell lines; these authors did not examine the levels of miR-143 and miR-145 precursors [53]. The results of these studies strongly suggest that miR-143 and -145 function as tumour suppressors and that deregulation in colorectal cancer and B-cell malignancies contributes to the tumourigenesis. This is of particular interest because it would exemplify the first tumour suppressive miRNAs whose expression is regulated by processing of the precursor. miR-7 inhibits the epidermal growth factor receptor and the Akt pathway
Deletions or mutations were not responsible for the reduction in miR-7 processing. These results indicate that there is a specific defect in the processing of the pri-miR-7 in glioblastomas.
Altered expression levels of Dicer in cancer
In a study of non-small-cell-lung cancer (NSCLC), it was determined that the expression levels of Dicer but not Drosha were reduced in a fraction of lung tumour tissues and that those patients with reduced Dicer expression had a poorer prognosis
Precursor lesions of peripheral adenocarcinoma of the lung (i.e. atypical adenomatous hyperplasia and bronchoalveolar carcinoma)
showed increased Dicer protein by immunohistochemistry [79] . The opposite was true for invasive and advanced adenocarcinoma, where Dicer protein was reduced [79] . The later phenomena may be partially explained by deletions in the Dicer locus [79] . This same group of researchers studied the Dicer protein expression in specimens of mucoepidermoid carcinoma (MEC) and correlated the Dicer expression with survival [80] . They determined that Dicer protein expression could either be increased or decreased in MEC. The high-grade, stage-III/IV, margin positive MECs showed predominate increased Dicer expression, whereas the tumour specimens from patients over 55 years of age were predominately reduced [80] .
Evidence of post-transcriptional regulation of miRNA expression in cancer Thomson et al. used published messenger RNA data to approximate the pri-miRNA xpression of those miRNAs that are encoded within introns [29] . Thus, the expression levels of a large number of pri-miRNAs were determined in several tumours and normal tissues without additional profiling. Because the mature miRNA was profiled in this same data set [73] , it was possible to establish the correlation between the levels of pri-miRNA and mature miRNA in a number of normal tissues and tumours. Consistent with their data in the developing mouse, the expression of the primiRNA was more or less consistent between tumour and normal, whereas the levels of mature miRNA were considerably reduced in the malignancy compared to the normal tissue [29] . These authors conclude that the widespread down-regulation of miRNA in cancer is due to a failure at the Drosha processing step. This failure is not due to reduction in Drosha mRNA expression as the levels of Drosha mRNA in this set of tissues did not change [73] and therefore alternative explanations are necessary.
Perhaps the strongest case for a relationship between reduced mature miRNA expression and cancer comes from the study by Kumar et al. [81] . shRNAs to three regulators of miRNA processing (Drosha, DGCR8 and Dicer) [83, 84] and mature miRNA [85] to expression profile the precursor and mature miRNAs in a number of cancer cell lines, tumours and normal tissues [86] . Quite often, the miRNA precursor was present but not the mature miRNA. For example, the brain-specific miR-128a precursor was present in most of the 22 normal tissues at levels of several hundreds of copies per cell, however the mature miR-128a was expressed only in brain and skeletal muscle [86] . As [86] . In pancreas cancer, there was a predominate increase in the expression of a number of miRNAs [63, 64] , whereas in hepatocellular carcinoma, there was a predominate decrease in the miRNA expression [55, 56] (Fig. 1) . Known mechanisms include binding of hnRNPs to the pri-miRNA [38] , A-to-I editing of the pri-/precursor miRNA [41] [42] [43] , mutations on the miRNA precursors that likely affect processing [45] , the presence of inhibitory proteins that regulate processing [30, 31] , altered levels of Dicer and/or Drosha [74, 76] , regulation by the TGF-␤ family signalling pathways [87] and sequestration in different cells types [34] . Because processing proteins (e.g. Drosha, Dicer, DCGR8, etc.) produce global effects on miRNA processing, it is unlikely that situations of altered processing result from altered levels of these factors. More than likely, regulation of processing results from miRNA-specific factors that aid or inhibit processing of the precursors [30-32, 38, 87] 
